Mikhail Blagosklonny is a scientist who is well known for his studies on cancer and aging. He was formerly an oncology professor at the Roswell Park Cancer Institute in New York. As a philanthropist, he believes that every individual should receive the best treatment possible despite their economic standing. Dr. Mikhail is renowned for advocating for the use of Rapamycin, a cancer drug thought to have the ability to increase the lifespan of a human being. The drug according to Dr. Mikhail has immunosuppressant properties and in fact, works better than other immunosuppressive drugs. In a deeper context, during organ transplants, the human body is prone to reject newly transplanted organs in which the procedure fails. Therefore, doctors will prescribe anti-rejection drugs commonly known as immunosuppressive drugs that have adverse effects on kidneys. Rapamycin enhances the immune response of the body towards tumors. Consequently, it promotes tumor regression hence the drug reduces the risk of cancer in patients with organ transplants by a landslide.
Moreover, Dr. Mikhail’s extensive research tests on mice have proven that use of Rapamycin on aging mice has resulted in extended immunity against tuberculosis. Tests on the elderly have shown the ability of the drug to rejuvenate the immune system against influenza. On the contrary, there is no up to date conclusive evidence that the drug can increase the lifespan of a person. Presently, scientists are in the process of conducting tests on a monkey to prove Dr. Mikhail’s belief that the drug can indeed increase human longevity. Research in progress on the treatment of muscular dystrophy has shown a positive effect of the grip strength of mice after Rapamycin inducement. Consequently, the mice also displayed improved cardiac functions, hence the potential ability to cure muscular dystrophy.Dr. Mikhail’s goal is to figure out a way to treat cancer which has become a modern day menace, in an efficient manner that will be pain-free and inexpensive.
He studies aging as well as cancer with the ideology that the two somehow correlate. He argues that from his research cancer, is common in older individuals above a certain age. With a bid to pass the information to the future generation who might uncover the misery, Dr. Mikhail has inspired his peers and students who want to be part of the evolution in his research study.While striving to come up with effective methods to treat cancer, he goes ahead to necessitate on creating a treatment that will eliminate the cancerous cells without necessarily destroying the unaffected cells; which help in the recovery of the body after cancer treatment. Like any other pacesetter, he believes that his work and findings in the oncology field will attract similar minds that will help take the research forward even after he leaves. The search for cancer treatment currently is expensive and is afforded by the few financially advantaged; he hopes to put all that to an end with his research, aiding all other future generations.